US Pharma MarketingThe post FDA clears Zeta Surgical’s robotic TMS navigation system appeared first on Medical Device Network.
FDA clears Zeta Surgical’s robotic TMS navigation system
Transcranial magnetic stimulation (TMS) is primarily used as an alternative or add-on depression treatment and for addressing behavioural- and addiction-based disorders. Transcranial magnetic stimulation (TMS) is primarily used as an alternative or add-on depression treatment and for addressing behavioural- and addiction-based disorders. According to GlobalData analysis, the global neuromodulation device market is projected to reach a valuation of over $13bn in 2035, up from around $6.8bn in 2025. Credit: ArtemisDiana/Shutterstock.com Zeta Surgical’s transcranial magnetic stimulation (TMS) robotic navigation system, designed to make delivering the treatment modality in treatment-resistant depression (TRD) more reproducible, has obtained US Food and Drug Administration (FDA)…
Transcranial magnetic stimulation (TMS) is primarily used as an alternative or add-on depression treatment and for addressing behavioural- and addiction-based disorders.
Source: Medical Device Network